Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nadine Jackson McCleary, M.D.

Concepts (225)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colonic Neoplasms10202225051.640 Why?
Colorectal Neoplasms14202367481.260 Why?
Gastrointestinal Neoplasms420239500.990 Why?
Rectal Neoplasms3202211650.960 Why?
Fluorouracil8202216030.900 Why?
Antineoplastic Combined Chemotherapy Protocols182023115850.680 Why?
Geriatric Assessment4201713690.650 Why?
Clinical Trials, Phase III as Topic420188510.640 Why?
Chemotherapy, Adjuvant10202234780.620 Why?
Mouth Neoplasms120235890.620 Why?
Electronic Health Records5202345650.590 Why?
Early Termination of Clinical Trials12017690.590 Why?
Self-Help Groups120181850.580 Why?
Camptothecin520225910.540 Why?
Cancer Care Facilities120184170.510 Why?
Bone Marrow Neoplasms120141010.450 Why?
Data Collection2201332970.440 Why?
Self Care120187810.440 Why?
Leucovorin620226230.430 Why?
Deoxycytidine320138450.410 Why?
Peripheral Nervous System Diseases320226870.400 Why?
Adenocarcinoma6202263020.380 Why?
Organoplatinum Compounds520194020.330 Why?
Age Factors72017181600.300 Why?
Neoplasms92022217230.300 Why?
Randomized Controlled Trials as Topic52018100960.290 Why?
Pancreatic Neoplasms6202352610.290 Why?
Quality Improvement2201837410.270 Why?
Aged, 80 and over172022576270.260 Why?
Patient Participation3202014110.260 Why?
Esophageal Neoplasms3202116170.260 Why?
HSP90 Heat-Shock Proteins220204290.240 Why?
Aged3320241644720.240 Why?
Electronics220223200.230 Why?
Neoplasm Staging102019110790.230 Why?
Liver Neoplasms3201442520.220 Why?
Research Design2202260660.210 Why?
Quality of Life62024129800.210 Why?
Communication Barriers220224110.200 Why?
Triazoles220209010.200 Why?
Humans5720247468970.200 Why?
Neoplasm Metastasis5201748270.190 Why?
Antineoplastic Agents62022135810.190 Why?
Middle Aged2920242147110.190 Why?
Disease-Free Survival9201467910.190 Why?
Male3320243515560.180 Why?
Anus Neoplasms120243270.180 Why?
Neoplasms, Unknown Primary120201020.170 Why?
Stomach Neoplasms2202013610.170 Why?
Female3320243826170.170 Why?
Adult2220242152910.160 Why?
Patient Education as Topic2202022810.160 Why?
Neutropenia120238830.150 Why?
Patient Selection1201041970.150 Why?
Patient Acceptance of Health Care2202430680.150 Why?
Feasibility Studies3202350960.140 Why?
Esophagogastric Junction120193260.140 Why?
Medical Oncology3202322690.130 Why?
Diagnostic Techniques and Procedures120182150.130 Why?
Palliative Care3202035490.130 Why?
Prognosis82020290880.120 Why?
Anemia, Myelophthisic1201460.120 Why?
Comorbidity22022103780.120 Why?
Tumor Lysis Syndrome12014400.120 Why?
Cholecalciferol120195380.120 Why?
Emigrants and Immigrants120205310.120 Why?
Antimetabolites, Antineoplastic120176370.110 Why?
Leukemia1202215000.110 Why?
Disseminated Intravascular Coagulation120141870.110 Why?
Tegafur12013360.110 Why?
Life Expectancy1202012220.110 Why?
Focus Groups1201813370.110 Why?
Minority Groups1202011970.110 Why?
Phenylurea Compounds220135280.110 Why?
Smoking1201089830.110 Why?
Karnofsky Performance Status120131660.110 Why?
Papillomavirus Infections1202415820.100 Why?
Perception1201811800.100 Why?
Diabetic Retinopathy1202012460.100 Why?
Carcinoma, Hepatocellular2201422560.090 Why?
CpG Islands1201511990.090 Why?
Gene Expression Profiling2201893290.090 Why?
Decision Support Techniques1202119580.090 Why?
Vitamins1201916110.090 Why?
Informed Consent120179820.090 Why?
Proto-Oncogene Proteins B-raf3202320300.090 Why?
Treatment Outcome102022637670.090 Why?
Food Hypersensitivity120186870.090 Why?
Hydroxychloroquine120144210.090 Why?
Survival Rate32019126510.090 Why?
Fatal Outcome1201418230.080 Why?
Software1202344010.080 Why?
Patient-Centered Care1201914000.080 Why?
Sirolimus2201315320.080 Why?
Tumor Microenvironment2202336970.080 Why?
Carcinoma, Squamous Cell1202439860.080 Why?
Colectomy120136680.080 Why?
Safety1201211510.080 Why?
Quinolines120137440.080 Why?
Carcinoma, Pancreatic Ductal1201816730.070 Why?
Genomics2202356990.070 Why?
Neuroendocrine Tumors120136420.070 Why?
Case-Control Studies22015217020.070 Why?
Quinazolines1201313550.070 Why?
Dietary Supplements1201933240.070 Why?
Autophagy1201413220.070 Why?
Practice Guidelines as Topic2202172810.060 Why?
Survival Analysis22021101390.060 Why?
Receptor Protein-Tyrosine Kinases1201316410.060 Why?
Risk Assessment42020234700.060 Why?
Physician-Patient Relations1201832030.060 Why?
Mass Screening1202053310.060 Why?
Combined Modality Therapy1201785220.060 Why?
Infusions, Intravenous1200922280.060 Why?
Melanoma1202355740.060 Why?
Physicians2202145370.060 Why?
Quality of Health Care1201942850.060 Why?
Mutation42023296430.060 Why?
Phosphatidylinositol 3-Kinases1201328680.060 Why?
Multiple Myeloma1202250960.060 Why?
TOR Serine-Threonine Kinases1201320560.060 Why?
Drug Resistance, Neoplasm2202051670.050 Why?
Genetic Variation1201864550.050 Why?
Kaplan-Meier Estimate4201364630.050 Why?
Vascular Endothelial Growth Factor A1201334750.050 Why?
DNA Methylation1201542600.050 Why?
National Cancer Institute (U.S.)120222910.050 Why?
Hypesthesia120211070.050 Why?
Pyridines1201328440.050 Why?
Administration, Oral1200939780.050 Why?
Prospective Studies32024532760.050 Why?
Granulocyte Colony-Stimulating Factor120236210.050 Why?
Multimedia12020740.040 Why?
Pyrimidinones120233800.040 Why?
Mitogen-Activated Protein Kinase Kinases120236370.040 Why?
Proportional Hazards Models42019122810.040 Why?
Sulfonamides1200919550.040 Why?
Decision Making1201338560.040 Why?
Retrospective Studies52024783610.040 Why?
Pyrazoles1200919910.040 Why?
Corylus1201830.040 Why?
Physician Assistants120211880.040 Why?
Cell Proliferation12014103130.040 Why?
Penaeidae12018220.040 Why?
Smoking Cessation1201020700.040 Why?
Positron-Emission Tomography1201464190.040 Why?
Molecular Diagnostic Techniques120236070.040 Why?
Pyridones120237500.040 Why?
Nurse Practitioners120212660.040 Why?
Databases, Factual1201378140.040 Why?
Recurrence1201083880.040 Why?
Pamphlets12017710.040 Why?
Patients120238980.040 Why?
Eggs120181830.030 Why?
Culture120206230.030 Why?
Odds Ratio2202396000.030 Why?
Leukocytes, Mononuclear1202318240.030 Why?
Health Services Needs and Demand1202413910.030 Why?
Paclitaxel1202316930.030 Why?
Young Adult22021572210.030 Why?
Follow-Up Studies22019388120.030 Why?
Death120206650.030 Why?
Clinical Trials, Phase II as Topic120186270.030 Why?
Canada1202020900.030 Why?
Milk120184380.030 Why?
Double-Blind Method22019122310.030 Why?
Recombinant Proteins1202365170.030 Why?
Interviews as Topic1202026080.030 Why?
Multivariate Analysis22019120210.030 Why?
Adolescent32021863230.030 Why?
Protein Kinase Inhibitors2202356140.030 Why?
Video Recording120179470.020 Why?
Neoplasm Recurrence, Local1201091920.020 Why?
Massachusetts1202486100.020 Why?
Language1202014900.020 Why?
Lymphatic Metastasis1201929190.020 Why?
MAP Kinase Signaling System1201814820.020 Why?
Tomography, X-Ray Computed12014201390.020 Why?
Niacinamide120134140.020 Why?
Medical Record Linkage120122910.020 Why?
Guideline Adherence1202121900.020 Why?
Self Report1202135930.020 Why?
Maximum Tolerated Dose120139010.020 Why?
Sequence Analysis, RNA1201819800.020 Why?
Patient Compliance1202026760.020 Why?
Germ-Line Mutation1201818150.020 Why?
Microsatellite Instability120136970.020 Why?
DNA1202472140.020 Why?
Signal Transduction12013231580.020 Why?
Gene Expression Regulation, Neoplastic2201883640.020 Why?
Gene Regulatory Networks1201817000.020 Why?
Class I Phosphatidylinositol 3-Kinases120138830.020 Why?
Vascular Endothelial Growth Factor Receptor-1120135580.020 Why?
DNA Repair1201820170.020 Why?
Evidence-Based Medicine1202136470.020 Why?
Microtubule-Associated Proteins1201410830.020 Why?
ras Proteins1201310490.020 Why?
SEER Program1201215140.020 Why?
Socioeconomic Factors1202076850.020 Why?
Dose-Response Relationship, Drug12019107450.020 Why?
Clinical Trials as Topic1202279410.020 Why?
Lymphocytes1201425890.020 Why?
Liver Diseases1201412720.020 Why?
Proto-Oncogene Proteins p21(ras)1201316900.020 Why?
Vitamin D1201932390.020 Why?
Mice, Inbred C57BL12023216080.020 Why?
Cost-Benefit Analysis1201854670.020 Why?
Longitudinal Studies12021141260.020 Why?
Analysis of Variance1201362300.020 Why?
Polymerase Chain Reaction1201360720.010 Why?
Delivery of Health Care1202252590.010 Why?
Severity of Illness Index12021155620.010 Why?
Risk Factors12010724530.010 Why?
Animals320231665930.010 Why?
Mice22023802910.010 Why?
Proto-Oncogene Proteins1201344850.010 Why?
Neoplasm Proteins1201336140.010 Why?
Algorithms12021138160.010 Why?
United States22022704600.010 Why?
Cohort Studies12022405400.010 Why?
Liver1201473820.010 Why?
Predictive Value of Tests12013150100.010 Why?
Diabetes Mellitus, Type 212020119660.010 Why?
Disease Progression12013133260.010 Why?
Medicare1201265690.010 Why?
McCleary's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (225)
Explore
_
Co-Authors (112)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.